Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats

International Journal of Colorectal Disease

Volumn 13, Issue 4, 1998, Pages 169-172

  Shpitz, B ^a   Bomstein, Y ^a   Kariv, N ^a   Shalev, M ^a   Buklan, G ^a   Bernheim, J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZOXYMETHANE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; COLON POLYP; CONTROLLED STUDY; CRYPT CELL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; AZOXYMETHANE; CARCINOGENS; CHEMOPREVENTION; COLON; COLONIC NEOPLASMS; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031687993     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840050160     Document Type: Article

References (42)

1. Lippman SM, Benner SE, Hong WK (1994) Cancer chemoprevention. J Clin Oncol 12:851-873
2. Shpitz B, Medline A, Stern H (1995) The adenoma-carcinoma sequence. In: Mazier WP, Luchtenfield MA, Levien DH, Senagore AJ (eds) Surgery of the colon, rectum and anus. Saunders, Philadelphia, pp 552-564
3. Labayle D, Fischer D, Vielh P, et al (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-639
4. Giardello FM, Hamilton S, Krush AJ, et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313-1316
5. Morgan G (1996) Non-steroidal antiinflammatory drugs and the chemoprevention of colorectal and esophageal cancers. Gut 38:646-648
6. Tosteson TD, Greenberg ER, Baron JA (1995) Aspirin use and reduced occurrence of larse bowel adenomas. Gastroenterology 108:A39
7. Evans JM, McMahon AD, McGilchrist MM, et al (1995) Non-steroidal anti-infiammatory drugs, aspirin and colorectal cancer: a record-linkage case-control study in Tayside, Scotland. Gastroenterology 108:A464
8. Giavancucci E, Egan KM, Hunter DJ, et al (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614
9. Giavancucci E, Rimm EB, Stampfler MJ, et al (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121:241-246
10. Suh O, Mettlin C, Petrelli NJ (1993) Aspirin use, cancer and polyps of the large bowel. Cancer 72:1171-1177
11. Peleg I, Maibach HT, Brown SH, Wicox M (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154:394-399
12. Thun MJ, Namboodiri MM, Calle EE, et al (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322-1327
13. Logan RF, Littla J, Hawtin PG, Hardcastle A (1993) Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottinghamn faecal occult blood screening program. BMJ 307:285-289
14. Thun MJ, Namboodiri MM, Heath CW (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596
15. McLellan EA, Bird R (1988) Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res 48:6183-6186
16. McLellan EA, Bird R (1998) Aberrant crypts, potential preneoplastic lesiolls in the murine colon. Cancer Res 48:6187-6192
17. Pretlow TP, Barrow BJ, Scott Ashton W, et al (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51:1564-1567
18. Roncucci L, Stamp D, Medline A, et al (1991) Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22:287-294
19. Pretlow TP, O'Riordan MN, Pretlow TG, et al (1992) Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem 16G:55-62
20. Vivona AA, Shpitz B, Medline A, et al (1993) K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colonic carcinogenesis. Carcinogenesis 14:1777-1781
21. Pretlow TP, Roukhadze EV, O'Riodan MA, et al (1994) Carcinoembryonic antigen in human colonic aberrant crypt foci. Gastroenterology 107:1719-1725
22. Smith AJ, Stern HS, Penner M, et al (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54:5527-5530
23. Augenlicht HL, Richards C, Corner G, Pretlow TP (1996) Evidence of genomic instability in human colonic aberrant crypt foci. Oncogene 12:1767-1772
24. Shpitz B, Medline A, Hay K, et al (1996) The natural history of aberrant crypt foci: a surgica!lapproach. Dis Colon Rectum 39:763-767
25. Bruce R, Archer MC, Corpet D, et al (1993) Diet, aberrant crypt foci and colorectal cancer. Mutat Res 290:111-118
26. Rao CV, Desal D, Simi B, et al (1993) Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 53:4182-4188
27. Wargowich M, Chen CD, Harris C, Yang E, et al (1995) Inhibition of aberrant crypt foci by nonsteroidal anti-inflammatory asgnts and differentiation agents in the rat colon. Int J Cancer 60:515-519
28. Lam L, Zhang J (1991) Reduction of aberrant crypt foci formation in the colon of CF1 mice by potential chemopreventive agents. Carcinogenesis 12:2311-2315
29. Bird R (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55-71
30. Magnuson BA, Carr I, Bird RP (1993) Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 53:4499-4504
31. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52:5575-5589
32. Marcus AJ (1995) Editorial: aspirin as prophylaxis against colorectal cancer. N Engl J Med 333:656-658
33. Sano H, Kawahito Y, Wilder RL, et al (1995) Expression of cyclooxysenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785-3789
34. Reddy BS, Chinthalapatty VR, Selbert K (1966) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56:4566-4569
35. Gustafson-Svird C, Lilja I, et al (1996) Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and azoxymethane induced colonic tumors in rats. Gut 38:79-84
36. Lu X, Xie W, Reed D, Bradshaw WS, Simmons DL (1995) Non-steroidal antiinflammatory drugs cause apoptosis and induce cyclooxyeenase in chicken embryo fibroblasts. Proc Natl Acad Sci USA 92:7961-7965
37. Shiff S, Qiao L, Tsai L, Rigas B (1995) Sulindac-sulfide, an aspirin-like compound inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96:491-503
38. Shiff SJ, Koustos MI, Qiao L, Rigas B (1996) Aspirin and other NSAIDs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 222: 179-188
39. Barnes CJ, Lee M, Hardman WE, Cameron IL (1995) Aspirin, age and proximity to lymphoid nodules influence cell proliferation parameters in rat colonic crypts. Cell Prolif 28:59-71
40. Mereto E, Frencia L, Ghia M (1994) Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett 76:5-9
41. Craven PA, DeRubertis FR (1992) Effects of aspirin on 1,2-dimethvyhydrazineinduced colonic carcinogenesis. Carcinogenesis 3:541-546
42. Reddy BS, Rao CV, Rivenson A, Kelloff G (1993) Inhibitory effect of aspirin on azoxymethane-Induced colon carcinogenesis in FG344 rats. Carcinogenesis 14:1493-1497